332 results on '"Witzel, I"'
Search Results
2. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry
3. Vaginal injuries after consensual sexual intercourse — a survey among office-based gynecologists in Hamburg, Germany
4. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers
5. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry
6. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force
7. Therapiealgorithmen für das Mammakarzinom
8. Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry
9. Früherkennung von Karzinomen: Herausforderungen im Zeitalter der Multigenanalyse
10. 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC)
11. Plasma L-arginine metabolic profiling in breast cancer patients reflects differences in cellular gene expression and metabolic activities according to subtype – A translational study in human breast cancer
12. Breast cancer during pregnancy: from preclinical models to clinical studies
13. Long-term survival of HER2-positive breast cancer patients with brain metastases: subanalysis of the BMBC Registry
14. Meningeosis Carcinomatosa (MC) als Erstmanifestation einer Metastasierung bei triple – negativem Mammakarzinom unter (neo-)/adjuvanter Therapie — zwei Fallberichte
15. 269P Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry
16. 151P Tumor biology and immunology in patients (pts) with breast cancer occurring during pregnancy (BCP) compared to non-pregnant breast cancer pts
17. The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use
18. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC Registry
19. Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry
20. Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry
21. 170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry
22. 311P A global survey of the management of carcinomatous meningitis (CM) in breast cancer patients
23. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer
24. Myeloides Sarkom der Brust: Extramedulläre Manifestion eines AML-Rezidivs nach allogener Stammzelltransplantation - ein Case Report
25. Beurteilung der Zufriedenheit nach Mastektomien bei Patient:innen mit Geschlechtsinkongruenz/Geschlechtsdyphorie - Studienprotokoll einer Längsschnitterhebung mit 2 Erhebungszeitpunkten
26. Characteristics of patients with brain metastases from HER2-positive breast cancer
27. Characteristics of patients with brain metastases from HER2-positive breast cancer
28. 95MO Characteristics of patients with brain metastases from HER2-positive breast cancer
29. Impact of the Oncotype DX® Recurrence Score® Assay on therapy recommendations for ER-positive (ER+), node negative (N0) and node positive (N+) early breast cancer - Results of an interim analysis of the German decision impact study: V444
30. 44O Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation
31. Charakteristika und Überlebensanalyse der Patienten mit asymptomatischen Hirnmetastasen eines Mammakarzinoms
32. Diagnostik und Behandlung eines Brust-Implantat-assoziierten anaplastischen Lymphoms – ein Case Report
33. Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry – comparison of three different prognostic scores
34. Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system
35. Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases
36. Kommunikationsprozesse zwischen BRCA-Mutationsträger/innen und deren Familienangehörigen
37. Klinisch-pathologische Charakterisierung von 1078 Ratsuchenden mit pathogener CHEK2 Mutation aus dem Deutschen Konsortium Familiärer Brust- und Eierstockkrebs (DK-FBREK)
38. Diagnostik und Behandlung von Brustimplantat-assoziierten anaplastischen Lymphomen (Bia-ALCL) – ein Case Report
39. 149P Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores
40. Trastuzumab in pregnancy associated with poor fetal outcome
41. Clinical utility of determination of HER-2/neu and EGFR fragments in serum of patients with metastatic breast cancer
42. Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK)
43. 251 (PB-075) Poster - Plasma L-arginine metabolic profiling in breast cancer patients reflects differences in cellular gene expression and metabolic activities according to subtype – A translational study in human breast cancer
44. KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
45. PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy
46. Behandlung von inoperablen, schmerzhaften, exophytisch wachsenden Thoraxwandmetastasen mittels Elektrochemotherapie – ein case report
47. Clinical relevance of collagen protein degradation markers C3 M and C4 M in the serum of breast cancer patients treated with neoadjuvant therapy in the GeparQuinto trial
48. Behandlung von inoperablen flächigen kutanen Metastasen mittels intratumoraler Injektion von Mistel (Abnoba Viscum Fraxini) – ein case report
49. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
50. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.